Zhao Xing, Papadopoulos Anestis, Ibusuki Shinichi, Bichara David A, Saris Daniel B, Malda Jos, Anseth Kristi S, Gill Thomas J, Randolph Mark A
Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Division of Plastic Surgery, Massachusetts General Hospital, Harvard Medical School, WACC 435, 15 Parkman Street, Boston, MA, 02114, USA.
BMC Musculoskelet Disord. 2016 Jun 3;17:245. doi: 10.1186/s12891-016-1100-1.
Injuries to the human native cartilage tissue are particularly problematic because cartilage has little to no ability to heal or regenerate itself. Employing a tissue engineering strategy that combines suitable cell sources and biomimetic hydrogels could be a promising alternative to achieve cartilage regeneration. However, the weak mechanical properties may be the major drawback to use fully degradable hydrogels. Besides, most of the fully degradable hydrogels degrade too fast to permit enough extracellular matrix (ECM) production for neocartilage formation. In this study, we demonstrated the feasibility of neocartilage regeneration using swine articular chondrocytes photoencapsualted into poly (ethylene glycol) dimethacrylate (PEGDM) copolymer hydrogels composed of different degradation profiles: degradable (PEG-LA-DM) and nondegradable (PEGDM) macromers in molar ratios of 50/50, 60/40, 70/30, 80/20, and 90/10.
Articular chondrocytes were isolated enzymatically from juvenile Yorkshire swine cartilage. 6 × 10(7) cells cells were added to each milliliter of macromer/photoinitiator (I2959) solution. Nonpolymerized gel containing the cells (100 μL) was placed in cylindrical molds (4.5 mm diameter × 6.5 mm in height). The macromer/photoinitiator/chondrocyte solutions were polymerized using ultraviolet (365 nm) light at 10 mW/cm(2) for 10 mins. Also, an articular cartilaginous ring model was used to examine the capacity of the engineered cartilage to integrate with native cartilage. Samples in the pilot study were collected at 6 weeks. Samples in the long-term experimental groups (60/40 and 70/30) were implanted into nude mice subcutaneously and harvested at 6, 12 and 18 weeks. Additionally, cylindrical constructs that were not implanted used as time zero controls. All of the harvested specimens were examined grossly and analyzed histologically and biochemically.
Histologically, the neocartilage formed in the photochemically crosslinked gels resembled native articular cartilage with chondrocytes in lacunae and surrounded by new ECM. Increases in total DNA, glycosaminoglycan, and hydroxyproline were observed over the time periods studied. The neocartilage integrated with existing native cartilage.
Articular cartilage generation was achieved using swine articular chondrocytes photoencapsulated in copolymer PEGDM hydrogels, and the neocartilage tissue had the ability to integrate with existing adjacent native cartilage.
人体天然软骨组织损伤问题尤为突出,因为软骨几乎没有自我愈合或再生的能力。采用将合适的细胞来源与仿生水凝胶相结合的组织工程策略,可能是实现软骨再生的一种有前景的替代方法。然而,机械性能较弱可能是使用完全可降解水凝胶的主要缺点。此外,大多数完全可降解水凝胶降解速度太快,无法为新软骨形成提供足够的细胞外基质(ECM)生成。在本研究中,我们证明了使用光包封在由不同降解特性的聚(乙二醇)二甲基丙烯酸酯(PEGDM)共聚物水凝胶中的猪关节软骨细胞进行新软骨再生的可行性:可降解(PEG-LA-DM)和不可降解(PEGDM)大分子单体的摩尔比分别为50/50、60/40、70/30、80/20和90/10。
从幼年约克夏猪软骨中酶法分离关节软骨细胞。每毫升大分子单体/光引发剂(I2959)溶液中加入6×10⁷个细胞。将含有细胞的未聚合凝胶(100μL)置于圆柱形模具(直径4.5mm×高6.5mm)中。大分子单体/光引发剂/软骨细胞溶液在10mW/cm²的紫外光(365nm)下聚合10分钟。此外,使用关节软骨环模型来检查工程化软骨与天然软骨整合的能力。初步研究中的样本在6周时收集。长期实验组(60/40和70/30)的样本皮下植入裸鼠体内,并在6、12和18周时收获。另外,未植入的圆柱形构建体用作零时间对照。所有收获的标本均进行大体检查,并进行组织学和生化分析。
组织学上,光化学交联凝胶中形成的新软骨类似于天然关节软骨,并伴有陷窝内的软骨细胞且被新的ECM包围。在所研究的时间段内,总DNA、糖胺聚糖和羟脯氨酸均有增加。新软骨与现有的天然软骨整合。
使用光包封在共聚物PEGDM水凝胶中的猪关节软骨细胞实现了关节软骨生成,并且新软骨组织有能力与现有的相邻天然软骨整合。